Fig. 1
From: Challenges in validation of combination treatment strategies for CRC using patient-derived organoids
Organoids formation and signaling pathways of optimized drug combinations (ODCs). (A) Schematic representation of different steps in an in vitro drug screening process. (B) Different combinations of targeted therapies optimized using CRC PDOs and their known targeted signaling pathways. Created with BioRender